# Dana-Farber/Harvard Cancer Center

> **NIH NIH P30** · DANA-FARBER CANCER INST · 2020 · $99,661

## Abstract

Overall
Project Summary / Abstract
Now in its 17th year of operation, Dana-Farber/Harvard Cancer Center (DF/HCC) was the first consortium
model, NCI-designated Comprehensive Cancer Center in the country. The consortium is comprised of 1,100
members from five principal Harvard-affiliated hospitals and two Harvard health science schools: Beth Israel
Deaconess Medical Center (BIDMC), Boston Children's Hospital (BCH, Brigham and Women's Hospital
(BWH), Dana-Farber Cancer Institute (DFCI), Harvard Medical School (HMS), Harvard T. H. Chan School of
Public Health (HSPH), and Massachusetts General Hospital (MGH).
The progress presented in this proposal has required DF/HCC leadership, its combined resources, and, most
importantly, its consortium structure. The overarching scientific vision is to unite the members. The research of
the Center is carried out in Research Programs that cross both scientific and institutional boundaries. In
addition, the Center supports Shared Resources dedicated to enhancing scientific efficiency available to all
Center members. The unified clinical research infrastructure has made it easier for members to conduct clinical
trials across the Center. Indirect indications of scientific progress are the substantial growth in the Center's
grant portfolio, from $233 million in 1999 to $406 million in 2004, to $623 million in 2009, to $683M and the
award of multiple translational grants that transcend organizational boundaries (e.g., SPOREs, SCORs, P01s,
U01s, and SU2Cs). There is also an array of hypothesis-driven, Early Phase (pilot, I, I-II), and proof-of-concept
trials, made possible through the development and execution of the Center, that are conducted daily across the
consortium.

## Key facts

- **NIH application ID:** 10243082
- **Project number:** 3P30CA006516-55S8
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** LAURIE Hollis GLIMCHER
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $99,661
- **Award type:** 3
- **Project period:** 1997-03-10 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10243082

## Citation

> US National Institutes of Health, RePORTER application 10243082, Dana-Farber/Harvard Cancer Center (3P30CA006516-55S8). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10243082. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*